Dubuque Bank & Trust’s iRadimed IRMD Stock Holding History

Dubuque Bank & Trust’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$6K	–	384
2019 Q1	$6K	Buy	+200	New	+$5.24K	﹤0.01%	546

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dubuque Bank & Trust's IRMD Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of iRadimed (IRMD) in Q2 2019, closing a stake of 200 shares — an estimated $6K sold.

Dubuque Bank & Trust first reported a position in IRMD in Q1 2019 and held it in 1 quarter. The position peaked at $6K in Q1 2019. 54 funds tracked by Wall St. Rank hold IRMD as of Q2 2019.

Dubuque Bank & Trust reported no remaining iRadimed position as of Q2 2019 after selling out during the quarter.
Dubuque Bank & Trust sold 200 iRadimed shares in Q2 2019, an estimated $6K.
Dubuque Bank & Trust first reported a position in iRadimed in Q1 2019 and held it in 1 quarter.
Dubuque Bank & Trust's iRadimed position peaked at $6K in Q1 2019.
54 funds tracked by Wall St. Rank held iRadimed as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.